Related Experiment Video
Updated: May 6, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Ganoderiol A-enriched extract suppresses migration and adhesion of MDA-MB-231 cells by inhibiting FAK-SRC-paxillin
Guo-Sheng Wu1, Yue-Lin Song, Zhi-Qi Yin
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Abstract:
Cell adhesion, migration and invasion are critical steps for carcinogenesis and cancer metastasis. Ganoderma lucidum, also called Lingzhi in China, is a traditional Chinese medicine, which exhibits anti-proliferation, anti-inflammation and anti-metastasis properties. Herein, GAEE, G. lucidum extract mainly contains ganoderiol A (GA), dihydrogenated GA and GA isomer, was shown to inhibit the abilities of adhesion and migration, while have a slight influence on that of invasion in highly metastatic breast cancer MDA-MB-231 cells at non-toxic doses. Further investigation revealed that GAEE decreased the active forms of focal adhesion kinase (FAK) and disrupted the interaction between FAK and SRC, which lead to deactivating of paxillin. Moreover, GAEE treatment downregulated the expressions of RhoA, Rac1, and Cdc42, and decreased the interaction between neural Wiskott-Aldrich Syndrome protein (N-WASP) and Cdc42, which impair cell migration and actin assembly. To our knowledge, this is the first report to show that G.lucidum triterpenoids could suppress cell migration and adhesion through FAK-SRC-paxillin signaling pathway. Our study also suggests that GAEE may be a potential agent for treatment of breast cancer.
Insights
Ganoderma lucidum extract (GAEE) inhibits breast cancer cell adhesion and migration by disrupting key signaling pathways. This traditional medicine shows potential for breast cancer treatment by targeting focal adhesion kinase and Rho GTPases.
Area of Science:
- Oncology
- Pharmacology
- Cell Biology
Background:
- Cell adhesion, migration, and invasion are crucial for cancer metastasis.
- Ganoderma lucidum (Lingzhi) is a traditional Chinese medicine with known anti-cancer properties.
Purpose of the Study:
- To investigate the effects of Ganoderma lucidum extract (GAEE) on highly metastatic breast cancer cells.
- To elucidate the molecular mechanisms underlying GAEE's anti-metastatic effects.
Main Methods:
- Treatment of MDA-MB-231 breast cancer cells with GAEE at non-toxic doses.
- Analysis of cell adhesion, migration, and invasion.
- Western blotting to assess protein expression and interactions (FAK, SRC, paxillin, RhoA, Rac1, Cdc42, N-WASP).
Main Results:
- GAEE significantly inhibited cell adhesion and migration, with a slight effect on invasion.
- GAEE decreased active focal adhesion kinase (FAK) and disrupted FAK-SRC interaction, leading to paxillin deactivation.
- GAEE downregulated RhoA, Rac1, and Cdc42, impairing cell migration and actin assembly via N-WASP interaction.
Conclusions:
- Ganoderma lucidum triterpenoids suppress breast cancer cell migration and adhesion through the FAK-SRC-paxillin signaling pathway.
- GAEE demonstrates potential as a therapeutic agent for breast cancer treatment.
Related Concept Videos
Cancer Cell Migration through Invadopodia
MAPK Signaling Cascades
Cell Migration
Cell Migration

